Medical Science Liaison

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also developing a pre-clinical asset QTX-2102, an advanced, next-generation antifungal and antiparasitic therapy designed to enhance efficacy while minimizing toxicity. Our mission is to push the boundaries of treatment possibilities, delivering hope and life-changing solutions to those who need them most.

We are seeking an experienced contractor Medical Science Liaison (MSL) to support a multinational Phase 3 haematology/oncology clinical trial across Italy and Germany. This field-based role will focus on scientific engagement with investigators and treatment centres, supporting trial awareness, operational engagement, and high-quality scientific exchange within a compliant framework.

The successful candidate will work independently across a geographically distributed territory and act as a key scientific interface between the company and external stakeholders.

Primary territories:

• Italy
• Germany

Travel within the assigned territory and attendance at relevant scientific meetings/congresses will be required.

Approximately 70–80% field-focused activity expected.

• Develop and maintain scientific relationships with investigators, referral centres, and relevant healthcare professionals
• Support scientific engagement around an ongoing Phase 3 haematology clinical trial
• Deliver high-quality, non-promotional scientific exchange in compliance with applicable regulations and company SOPs
• Support trial awareness and operational engagement activities within assigned territories
• Identify and communicate field insights, including recruitment challenges, treatment landscape developments, and investigator feedback
• Support congress activities, investigator meetings, and scientific discussions as required
• Ensure timely and accurate documentation of activities and reporting of adverse events/product complaints in accordance with pharmacovigilance requirements
• Work cross-functionally with Medical Affairs, Clinical Operations, and other internal stakeholders

• Advanced scientific or healthcare degree (PharmD, PhD, MD, MSc or equivalent)
• Prior experience as a field-based MSL within oncology or haematology
• Strong scientific acumen and ability to communicate complex clinical data effectively
• Demonstrated ability to work independently across a multi-site territory
• Experience developing relationships with academic investigators and healthcare professionals
• Strong communication, presentation, and stakeholder engagement skills
• Experience working within GCP, pharmacovigilance, and compliance frameworks
• Experience within Italy and/or Germany is essential

• Italian language proficiency strongly preferred
• Prior experience in haematology and/or rare cancers
• Experience supporting Phase 2 or Phase 3 clinical trials
• Experience supporting recruitment or referral engagement activities for clinical trials
• Existing relationships within relevant haematology treatment centres
• Experience working in multinational European territories

• Field-based role
• Travel required across assigned territories